A randomised double blind controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

被引:1
|
作者
Leiper, K
Woolner, JT
Parker, TJ
van der Vleit, M
Mullan, MM
Fear, S
Rhodes, JM
Hunter, JO
机构
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Acad Hosp, Cambridge, England
[3] Roy Castle Int Ctr Lung Canc Res, Liverpool, Merseyside, England
关键词
D O I
10.1016/S0016-5085(00)84470-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
3032
引用
收藏
页码:A583 / A583
页数:1
相关论文
共 50 条
  • [21] The effects of high and low emulsifier diets in active Crohn's disease: A pilot double-blinded randomised feeding trial
    Fitzpatrick, J. A.
    Gibson, P. R.
    Taylor, K. M.
    Anderson, E. J.
    Friedman, A. B.
    Ardalan, Z. S.
    Smith, R. L.
    Halmos, E. P.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1451 - i1451
  • [22] RANDOMISED CONTROLLED TRIAL OF ANTIBIOTIC/HYDROXYCHLOROQUINE COMBINATION VERSUS STANDARD BUDESONIDE IN ACTIVE CROHN'S DISEASE (APRICOT)
    Rhodes, Jonathan
    Subramanian, Sreedhar
    Flanagan, Paul
    Horgan, Graham
    Martin, Kate
    Mansfield, John
    Parkes, Miles
    Hart, Ailsa
    Dallal, Helen
    Iqbal, Tariq
    Butterworth, Jeff
    Culshaw, Kate
    Probert, Christopher
    GUT, 2021, 70 : A4 - A5
  • [23] Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
    Mowat, Craig
    Arnott, Ian
    Cahill, Aiden
    Smith, Malcolm
    Ahmad, Tariq
    Subramanian, Sreedhar
    Travis, Simon
    Morris, John
    Hamlin, John
    Dhar, Anjan
    Nwokolo, Chuka
    Edwards, Cathryn
    Creed, Tom
    Bloom, Stuart
    Thomas, Linzi
    Campbell, Simon
    Lewis, Stephen J.
    Sebastian, Shaji
    Sen, Sandip
    Yousif, Mohamed
    Lal, Simon
    Hawkey, Chris
    Murray, Charles
    Cummings, Fraser
    Goh, Jason
    Lindsay, James O.
    Arebi, Naila
    Potts, Lindsay
    McKinley, Aileen J.
    Thomson, John M.
    Todd, John A.
    Collie, Mhairi
    Dunlop, Malcolm G.
    Mowat, Ashley
    Gaya, Daniel R.
    Winter, Jack
    Naismith, Graham D.
    Ennis, Holly
    Keerie, Catriona
    Lewis, Steff
    Prescott, Robin J.
    Kennedy, Nicholas A.
    Satsangi, Jack
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (04): : 273 - 282
  • [24] Prevention of recurrence by mesalamine (Pentasa) in pediatric Crohn's disease. A multicentric double blind trial
    Cezard, JP
    Munck, A
    Mouterde, O
    Morali, A
    Lenaerts, C
    Lachaux, A
    Turck, D
    Schmitz, J
    Maurage, C
    Girardet, JP
    Belli, D
    Lamireau, T
    Sarles, J
    Chouraqui, JP
    Descos, B
    Dabadi, A
    Meyer, M
    Olives, JP
    Crand, J
    Mary, JY
    GASTROENTEROLOGY, 2003, 124 (04) : A379 - A379
  • [25] Polymeric versus elemental diet as primary treatment in active Crohn's disease:: A randomized, double-blind trial
    Verma, S
    Brown, S
    Kirkwood, B
    Giaffer, MH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (03): : 735 - 739
  • [26] Randomized, double-blind, double-dummy, controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease
    Herrlinger, K
    Witthoeft, T
    Raedler, A
    Bokemeyer, B
    Krummenerl, T
    Schulzke, J
    Boerner, N
    Kueppers, B
    Emmrich, J
    Mescheder, A
    Schwertschlag, U
    Shapiro, M
    Stange, E
    GASTROENTEROLOGY, 2004, 126 (04) : A466 - A466
  • [27] Double blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
    Freeman, TB
    Goetz, CG
    Kordower, JH
    Stoessl, AJ
    Brin, MF
    Shannon, KM
    Perl, D
    Godbold, J
    Olanow, CW
    EXPERIMENTAL NEUROLOGY, 2003, 181 (01) : 91 - 91
  • [28] Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
    Neurath, MF
    Wanitschke, R
    Peters, M
    Krummenauer, F
    zum Büschenfelde, KHM
    Schlaak, JF
    GUT, 1999, 44 (05) : 625 - 628
  • [29] Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
    D'Haens, Geert
    Taxonera, Carlos
    Lopez-Sanroman, Antonio
    Nos, Pilar
    Danese, Silvio
    Armuzzi, Alessandro
    Roblin, Xavier
    Peyrin-Biroulet, Laurent
    West, Rachel
    Mares, Wout G. N.
    Duijvestein, Marjolijn
    Gecse, Krisztina B.
    Feagan, Brian G.
    Zou, Guangyong
    Hulshoff, Melanie S.
    Mookhoek, Aart
    Oldenburg, Lotte
    Bouhnik, Yoram
    Laharie, David
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (01): : 26 - 33
  • [30] A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease
    Mansfield, J. C.
    Parkes, M.
    Hawthorne, A. B.
    Forbes, A.
    Probert, C. S. J.
    Perowne, R. C.
    Cooper, A.
    Zeldis, J. B.
    Manning, D. C.
    Hawkey, C. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 421 - 430